Fennec Pharmaceuticals Names Chief Medical, Commercial, and Strategy Officers

MT Newswires Live

Oct 28, 2024

Fennec Pharmaceuticals (FENC) said Monday it has named Pierre S. Sayad as chief medical officer, Terry Evans as chief commercial officer, and Christiana Cioffi as chief strategy officer, starting immediately.

Sayad previously served as senior vice president of business development and global medical affairs at the International Myeloma Foundation. In the past, Sayad was a strategic management consultant for Campbell Alliance and served as chief operating officer and interim chief medical officer at Zephyr Labz.

Evans previously served as CEO of UNITE Pharma Trade Advisors. Evans also held roles at Currax Pharmaceuticals, Horizon Therapeutics (HZNP), Graceway Pharmaceuticals, and Medicis.

Cioffi joined Fennec from Disruptify Consulting where she had served as strategic advisor and leadership coach.

Price: 3.8500, Change: -0.39, Percent Change: -9.20

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2478102976"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2478102976\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2478102976?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-28 20:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2478102976","market":"sg","top_or_hot":-1,"title":"Fennec Pharmaceuticals Names Chief Medical, Commercial, and Strategy Officers","media":"MT Newswires Live","content":"<html><body><p> Fennec Pharmaceuticals (FENC) said Monday it has named Pierre S. Sayad as chief medical officer, Terry Evans as chief commercial officer, and Christiana Cioffi as chief strategy officer, starting immediately.</p><p>Sayad previously served as senior vice president of business development and global medical affairs at the International Myeloma Foundation. In the past, Sayad was a strategic management consultant for Campbell Alliance and served as chief operating officer and interim chief medical officer at Zephyr Labz.</p><p>Evans previously served as CEO of UNITE Pharma Trade Advisors. Evans also held roles at Currax Pharmaceuticals, Horizon <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (HZNP), Graceway Pharmaceuticals, and Medicis.</p><p>Cioffi joined Fennec from Disruptify Consulting where she had served as strategic advisor and leadership coach.</p><p>Price: 3.8500, Change: -0.39, Percent Change: -9.20</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fennec Pharmaceuticals Names Chief Medical, Commercial, and Strategy Officers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFennec Pharmaceuticals Names Chief Medical, Commercial, and Strategy Officers\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2024-10-28 20:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Fennec Pharmaceuticals (FENC) said Monday it has named Pierre S. Sayad as chief medical officer, Terry Evans as chief commercial officer, and Christiana Cioffi as chief strategy officer, starting immediately.</p><p>Sayad previously served as senior vice president of business development and global medical affairs at the International Myeloma Foundation. In the past, Sayad was a strategic management consultant for Campbell Alliance and served as chief operating officer and interim chief medical officer at Zephyr Labz.</p><p>Evans previously served as CEO of UNITE Pharma Trade Advisors. Evans also held roles at Currax Pharmaceuticals, Horizon <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (HZNP), Graceway Pharmaceuticals, and Medicis.</p><p>Cioffi joined Fennec from Disruptify Consulting where she had served as strategic advisor and leadership coach.</p><p>Price: 3.8500, Change: -0.39, Percent Change: -9.20</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0109394709.USD","symbol_name":"富兰克林生物科技新领域基金A (acc)","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2478102976","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2478102976","pubTimestamp":1730118040,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Fennec Pharmaceuticals  said Monday it has named Pierre S. Sayad as chief medical officer, Terry Evans as chief commercial officer, and Christiana Cioffi as chief strategy officer, starting immediately.Sayad previously served as senior vice president of business development and global medical affairs at the International Myeloma Foundation. In the past, Sayad was a strategic management consultant for Campbell Alliance and served as chief operating officer and interim chief medical officer at Zephyr Labz.Evans previously served as CEO of UNITE Pharma Trade Advisors. Evans also held roles at Currax Pharmaceuticals, Horizon Therapeutics , Graceway Pharmaceuticals, and Medicis.Cioffi joined Fennec from Disruptify Consulting where she had served as strategic advisor and leadership coach.Price: 3.8500, Change: -0.39, Percent Change: -9.20","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","HZNP":"Horizon Pharma","BK4532":"文艺复兴科技持仓","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","BK4139":"生物科技","FENC":"Fennec Pharmaceuticals Inc.","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1"},"translate_title":"Fennec Pharmaceuticals任命首席医疗、商业和战略官","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"FENC":0.9,"HZNP":0.9},"content_text":"Fennec Pharmaceuticals (FENC) said Monday it has named Pierre S. Sayad as chief medical officer, Terry Evans as chief commercial officer, and Christiana Cioffi as chief strategy officer, starting immediately.Sayad previously served as senior vice president of business development and global medical affairs at the International Myeloma Foundation. In the past, Sayad was a strategic management consultant for Campbell Alliance and served as chief operating officer and interim chief medical officer at Zephyr Labz.Evans previously served as CEO of UNITE Pharma Trade Advisors. Evans also held roles at Currax Pharmaceuticals, Horizon Therapeutics (HZNP), Graceway Pharmaceuticals, and Medicis.Cioffi joined Fennec from Disruptify Consulting where she had served as strategic advisor and leadership coach.Price: 3.8500, Change: -0.39, Percent Change: -9.20","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}